Recbio Develops Lyophilized mRNA Vaccine Against Corona Virus
Posted on
China’s biotechnology company Recbio has developed the first lyophilized mRNA vaccine that offers long-term stability and strong immunogenicity against the COVID-19 virus.
The post Recbio Develops Lyophilized mRNA Vaccine Against Corona Virus appeared first on Army Technology.
Subscribe to our newsletter
Promotions, new products and sales. Directly to your inbox.
Quick links
© Copyright 2024, Morale Patch® Armory.